Cervical Neoplasia
11
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
1 terminated out of 11 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (11)
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe
Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
Costa Rican Natural History Study of HPV and Cervical Neoplasia
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
Thermal Imaging for Evaluation of the Cervix
Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device
Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia
Feasibility of Delphi Screener for Cervical Cytology
Spectroscopic Evaluation of Cervical Neoplasia